Signalisation de l'Invasion tumorale : P. Coopman


Bertho M, Fraisse J, Patsouris A, Cottu P, Arnedos M, Pérol D, Jaffré A, Goncalves A, Lebitasy M-P, D'Hondt V, Dalenc F, Ferrero J-M, Levy C, Dabakuyo S, Rouzier R, Penault-Llorca F, Uwer L, Eymard J-C, Breton M, Chevrot M, Thureau S, Petit T, Simon G Real-life prognosis of 5041 bone-only metastatic breast cancer patients in the multicenter national observational ESME program. Ther Adv Med Oncol. 2021;13. doi:10.1177/1758835920987657

Aptecar L, Fiteni F, Jarlier M, Guillerme V, Jacot W Prospective evaluation of sexual health in breast cancer women during the first year of adjuvant hormonal treatment using a cancer patient's dedicated questionnaire: A glaring gap of communication between health professionals and patients. Breast Cancer Res Treat. 2021-01-15. doi:10.1007/s10549-020-06062-x

Buffard M, Naldi A, Freiss G, Deckert M, Radulescu O, Coopman P, Larive R Comparison of SYK Signaling Networks Reveals the Potential Molecular Determinants of Its Tumor-Promoting and Suppressing Functions. Biomolecules. 2021;11(2). doi:10.3390/biom11020308

Blateau P, Coyaud E, Ducros V, Chauchard G, Vendrell J, Solassol J TERT Promoter Mutation as an Independent Prognostic Marker for Poor Prognosis MAPK Inhibitors-Treated Melanoma. Cancers (Basel). 2020;12(8). doi:10.3390/cancers12082224

Heudel P, Delaloge S, Parent D, Madranges N, Levy C, Dalenc F, Brain E, Uwer L, Augereau P, Mailliez A, Perrin C, Sablin M-P, Mouret-Reynier M-A, Vermeulin T, Eymard J-C, Petit T, Ferrero J-M, Ilie S, Goncalves A, Chenuc G, Robain M Real-world Evaluation of Oral Vinorelbine in the Treatment of Metastatic Breast Cancer: An ESME-MBC Study. Anticancer Res.. 2020;40(7):3905-3913. doi:10.21873/anticanres.14381

Hamyeh M, Bernex F, Larive R, Naldi A, Urbach S, Simony-Lafontaine J, Puech C, Bakhache W, Coopman P, Hendriks W, Freiss G PTPN13 induces cell junction stabilization and inhibits mammary tumor invasiveness. Theranostics. 2020;10(3):1016-1032. doi:10.7150/thno.38537

Béganton B, Coyaud E, Laurent E, Mangé A, Jacquemetton J, Le Romancer M, Raught B, Solassol J Proximal Protein Interaction Landscape of RAS Paralogs. Cancers. 2020;12(11):3326. doi:10.3390/cancers12113326

Conte P, Schneeweiss A, Loibl S, Mamounas E, von Minckwitz G, Mano M, Untch M, Huang C-S, Wolmark N, Rastogi P, Stamatovic L, Bonnefoi H, Castro-Salguero H, Fischer H, Wahl T, Song C, Boulet T, Trask P, Geyer C Patient-reported outcomes from KATHERINE: A phase 3 study of adjuvant trastuzumab emtansine versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for human epidermal growth factor receptor 2-positive breast cancer. Cancer. 2020;126(13):3132-3139. doi:10.1002/cncr.32873

Garnier S, Vendrell J, Boillot B, Karsenty G, Faure A, Blanc T, Soustelle L, Phe V, Even A, Chartier-Kastler E, Ravasse P, Poinas G, Leizour B, Costa P, Galmiche L, Iborra F, Bouali O, Solassol J, Kalfa N Malignancy after Augmentation Enterocystoplasty: A Nationwide Study of Natural History, Prognosis and Oncogene Panel Analysis. J. Urol.. 2020;204(1):136-143. doi:10.1097/JU.0000000000000752

Frank S, Carton M, Dubot C, Campone M, Pistilli B, Dalenc F, Mailliez A, Levy C, D'Hondt V, Debled M, Vermeulin T, Coudert B, Perrin C, Uwer L, Ferrero J-M, Eymard J-C, Petit T, Mouret-Reynier M-A, Patsouris A, Guesmia T, Bachelot T, Robain M, Cottu P Impact of age at diagnosis of metastatic breast cancer on overall survival in the real-life ESME metastatic breast cancer cohort. Breast. 2020;52. doi:10.1016/j.breast.2020.04.009

Mancini M, Papon L, Mangé A, Cammas F, Fabbrizio E HP1s modulate the S-Adenosyl Methionine synthesis pathway in liver cancer cells. Biochem. J.. 2020;477(5):1033-1047. doi:10.1042/BCJ20190621

Mcheik S, Aptecar L, Coopman P, D'Hondt V, Freiss G Dual Role of the PTPN13 Tyrosine Phosphatase in Cancer. Biomolecules. 2020;10(12). doi:10.3390/biom10121659

Béganton B, Coyaud E, Mangé A, Solassol J [New approaches for protein-protein interaction study]. Med Sci (Paris). 2019;35(3):223-231. doi:10.1051/medsci/2019035

Vendrell J, Senal R, Rouquette I, Quantin X, Pujol J-L, Bouidioua A, Godreuil S, Coyaud E, Brousset P Ultra-sensitive EGFRT790Mdetection as an independent prognostic marker for lung cancer patients harboring EGFRdel19mutations and treated with first-generation TKIs. Clin. Cancer Res.. Apr 01, 2019. doi:10.1158/1078-0432.CCR-18-2683

D'Hondt V, Canon J-L, Roca L, Levy C, Pierga J-Y, Le Du F, Campone M, Desmoulins I, Goncalves A, Debled M, Rios M, Ferrero J-M, Serin D, Hardy-Bessard A-C, Piot G, Brain E, Dohollou N, Orfeuvre H, Roché H, Delaloge S, Dalenc F UCBG 2-04: Long-term results of the PACS 04 trial evaluating adjuvant epirubicin plus docetaxel in node-positive breast cancer and trastuzumab in the human epidermal growth factor receptor 2-positive subgroup. Eur. J. Cancer. 2019;122. doi:10.1016/j.ejca.2019.09.014

Pichard A, Marcatili S, Karam J, Constanzo J, Ladjohounlou R, Courteau A, Jarlier M, Bonnefoy N, Patzke S, Stenberg V, Coopman P, Cartron G, Navarro-Teulon I, Repetto-Llamazares A, Heyerdahl H, Dahle J, Bardiès M, Pouget J-P The therapeutic effectiveness of 177Lu-lilotomab in B-cell non-Hodgkin lymphoma involves modulation of G2/M cell cycle arrest. Leukemia. 2019;34(5):1315-1328. doi:10.1038/s41375-019-0677-4

Kassouf T, Larive R, Morel A, Urbach S, Bettache N, Marcial Medina M, Mèrezègue F, Freiss G, Peter M, Boissière-Michot F, Solassol J, Montcourrier P, Coopman P The Syk Kinase Promotes Mammary Epithelial Integrity and Inhibits Breast Cancer Invasion by Stabilizing the E-Cadherin/Catenin Complex. Cancers (Basel). 2019;11(12). doi:10.3390/cancers11121974

Nziza N, Jeziorski E, Delpont M, Cren M, Chevassus H, Carbasse A, Mahe P, Abassi H, Joly-Monrigal P, Schordan E, Mangé A, Jorgensen C, Apparailly F, Duroux-Richard I Synovial-Fluid miRNA Signature for Diagnosis of Juvenile Idiopathic Arthritis. Cells. 2019;8(12). doi:10.3390/cells8121521

Tümmler C, Dumitriu G, Wickström M, Coopman P, Valkov A, Kogner P, Johnsen J, Moens U, Sveinbjörnsson B SYK Inhibition Potentiates the Effect of Chemotherapeutic Drugs on Neuroblastoma Cells in Vitro. Cancers (Basel). 2019;11(2). doi:10.3390/cancers11020202

Lacombe J, Brengues M, Mangé A, Bourgier C, Gourgou S, Pèlegrin A, Ozsahin M, Solassol J, Azria D Quantitative proteomic analysis reveals AK2 as potential biomarker for late normal tissue radiotoxicity. Radiat Oncol. 2019;14(1):142. doi:10.1186/s13014-019-1351-8

Alegre N, Perre P, Bignon Y, Michel A, Galibert V, Mophawe O, Corsini C, Coupier I, Chiesa J, Robert L, Bernhard L, Picot M-C, Bertet H, Macioce V, Bastide N, Solassol J, Rey J, Thomas F, Carton S, Pujol P Psychosocial and clinical factors of probands impacting intrafamilial disclosure and uptake of genetic testing among families with BRCA1/2 or MMR gene mutations. Psychooncology. Jun 01, 2019. doi:10.1002/pon.5142

Béganton B, Solassol I, Mangé A, Solassol J Protein interactions study through proximity-labeling. Expert Rev Proteomics. Jul 04, 2019. doi:10.1080/14789450.2019.1638769

Buffard M, Naldi A, Radulescu O, Coopman P, Larive R, Freiss G Network Reconstruction and Significant Pathway Extraction Using Phosphoproteomic Data from Cancer Cells. Proteomics. 2019;19(21-22):e1800450. doi:10.1002/pmic.201800450

Escudié F, Van Goethem C, Grand D, Vendrell J, Vigier A, Brousset P, Evrard S, Solassol J, Selves J MIAmS: microsatellite instability detection on NGS amplicons data. Bioinformatics. Oct 24, 2019. doi:10.1093/bioinformatics/btz797

Mangé A, Coyaud E, Desmetz C, Coopman P, Raught B, Solassol J FKBP4 connects mTORC2 and PI3K to activate the PDK1/Akt-dependent cell proliferation signaling in breast cancer. Theranostics. 2019;9(23):7003-7015. doi:10.7150/thno.35561

© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés